In Section C, individuals will get ABBV-744 and oral navitoclax. In Section D, members will obtain ABBV-744 and ruxolitinib. Individuals will obtain treatment until ailment progression or perhaps the individuals are not able to tolerate the study drugs. - Participant eaten grapefruit or grapefruit goods within 3 times ahead of https://charlesj665xju9.activablog.com/profile